Veritable, L.P. Abbott Laboratories Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $126,680 - $141,148	-1,257 Reduced 1.22%	101,709 $11.1 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $1.26 Million - $1.48 Million	-12,975 Reduced 11.19%	102,966 $10.4 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $8,270 - $9,702	87 Added 0.08%	115,941 $12.7 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $648,775 - $751,161	-6,705 Reduced 5.47%	115,854 $11.2 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $165,863 - $200,476	1,625 Added 1.34%	122,559 $13.3 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $237,275 - $289,342	-2,081 Reduced 1.69%	120,934 $14.3 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $291,828 - $357,327	2,526 Added 2.1%	123,015 $17.3 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $29,398 - $32,523	-252 Reduced 0.21%	120,489 $14.2 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $1.27 Million - $1.5 Million	-12,036 Reduced 9.06%	120,741 $14 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $132,349 - $155,927	-1,216 Reduced 0.91%	132,777 $15.9 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $181,230 - $197,488	-1,726 Reduced 1.27%	133,993 $14.7 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $31,799 - $38,617	-347 Reduced 0.26%	135,719 $14.8 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $306,203 - $391,902	3,999 Added 3.03%	136,066 $12.4 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $289,851 - $423,842	-4,614 Reduced 3.38%	132,067 $10.4 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $168,168 - $187,210	2,142 Added 1.59%	136,681 $11.9 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $17,350 - $18,812	-212 Reduced 0.16%	134,539 $11.3 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $144,229 - $168,215	-1,979 Reduced 1.45%	134,751 $11.3 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $5,165 - $6,244	78 Added 0.06%	136,730 $10.9 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $21,110 - $23,914	322 Added 0.24%	136,652 $9.88 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $167,045 - $201,519	2,747 Added 2.06%	136,330 $10 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $167,586 - $184,964	-2,911 Reduced 2.13%	133,583 $8.15 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $91,269 - $103,191	1,622 Added 1.2%	136,494 $8.18 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $788,773 - $844,464	-14,694 Reduced 9.82%	134,872 $7.7 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $7.19 Million - $8.02 Million	149,566	149,566 $7.98 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.06 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.77 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.3 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account